About iHealthOmics
iHealthOmics is a Technology company based in Agra (India) founded in 2018. It develops innovative AI technologies for molecular biomarker solutions. It operates on a B2B model. Its focus areas include Healthcare, Biotechnology, Molecular Diagnostics and AI Biomarkers. Similar companies include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group and 5 more; 8 of its 10 listed similar companies have raised funding.
Company details
iHealthOmics, founded in 2018 in Agra, India, focuses on providing healthcare solutions, advancing biotech innovations, molecular diagnostics, and ai biomarkers. Develops innovative AI technologies for molecular biomarker solutions. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Agra, India
- SectorsTechnology
- Email••••••••
- Website ihealthomics.com
Similar companies to iHealthOmics
iHealthOmics has 10 listed similar companies in our database, 8 of them funded. They include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed similar companies of iHealthOmics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in AI in Medical Diagnostics
10 companies that operate in the same segment as iHealthOmics (AI in Medical Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Early-stage investments in digital, climate, and deep science technologies. | 2011 | Mumbai, Maharashtra, India | – | USD 1.11 M | – | |
Deep tech innovation in IoT and AI for startups and enterprises in India. | 2015 | Bengaluru, Karnataka, India | – | – | – | |
Creates AI technologies for surgical planning, robotics, and cloud-based tools. | 2018 | Mumbai, Maharashtra, India | USD 120 K | – | – | |
Health services are provided via cordys.health domain. | 2022 | Netherlands | USD 947.57 K | – | – | |
Offers AI-powered digital solutions, engineering, IT services, and talent management globally. | 1992 | Bengaluru, Karnataka, India | – | USD 108.7 M | 3,441 | |
Offers AI consulting, data analytics, and product engineering for various industries. | 2014 | Ghaziabad, Uttar Pradesh, India | – | USD 1.4 M | 55 | |
An AI-powered tool for analyzing chest X-rays to support COVID interventions. | 2021 | Bengaluru, Karnataka, India | – | USD 177.48 K | 24 | |
Provides data-driven health optimization, diagnostics, and AI care for individuals and businesses. | 2016 | Bengaluru, Karnataka, India | – | USD 508.49 K | 31 | |
Venture capital investing in European HealthTech innovators for healthcare advancements. | 2021 | Munchen, Bayern, Germany | – | – | – | |
Provides medical imaging analysis for clinical trials using AI and secure data processing. | 2012 | Bengaluru, Karnataka, India | – | USD 487.68 K | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about iHealthOmics
iHealthOmics was founded in 2018.
iHealthOmics is headquartered in Agra, India. It is registered at Agra, Uttar Pradesh, India.
iHealthOmics, founded in 2018 in Agra, India, focuses on providing healthcare solutions, advancing biotech innovations, molecular diagnostics, and ai biomarkers. Develops innovative AI technologies for molecular biomarker solutions. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
iHealthOmics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.